TCT
This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures.
News | Cardiac Diagnostics | September 21, 2018
September 21, 2018 — At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego,...
Feature | TCT | September 21, 2018
October 4, 2018 – The Cardiovascular Research Foundation (CRF) had 15 late-breaking trials and 12 late-breaking...
News | Cath Lab | September 20, 2018
September 20, 2018 — At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego,...
News | Heart Failure | September 20, 2018
September 20, 2018 — Cardiac Dimensions announced the company has randomized its first patient in the CARILLON Pivotal...
News | Hemodynamic Support Devices | September 20, 2018
September 19, 2018 — Abiomed Inc. announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (TCT...
Technology | Cardiovascular Ultrasound | September 19, 2018
September 19, 2018 — DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound...
News | Heart Valve Technology | September 19, 2018
September 19, 2018 – The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE...
News | Heart Valve Technology | September 17, 2018
September 17, 2018 — 4C Medical Technologies Inc. announced that its AltaValve transcatheter mitral valve replacement (...
Feature | TCT | September 14, 2018 | Dave Fornell, Editor
The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT)...
Technology | Heart Valve Technology | July 18, 2018
July 18, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for a next-...
William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support.
Feature | Hemodynamic Support Devices | June 22, 2018 | Dave Fornell, Editor
About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients a...
Technology | Annuloplasty Rings | June 15, 2018
June 15, 2018 — LivaNova PLC announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its...
Technology | Drug-Eluting Balloons | June 15, 2018
June 15, 2018 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths...
Technology | Stents Drug Eluting | May 25, 2018
May 25, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for Xience Sierra...
An example of Siemens' syngo CTO navigation technology that fuses computed tomogragraphy (CT) imaging with live angiography to help navigate chronic total occlusion vessel segments that are occluded and not visible on angiography alone.
Feature | Chronic Total Occlusion (CTO) | February 20, 2018 | Dave Fornell
One of the recent hot topics in interventional cardiology has been how operators can use new tools and techniques to...
